Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

In Haiti, 22 communes still require mass drug administration (MDA) to eliminate lymphatic filariasis (LF) as a public health problem. Several clinical trials have shown that a single oral dose of ivermectin (IVM), diethylcarbamazine (DEC) and albendazole (ALB) (IDA) is more effective than DEC plus A...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Christine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars, Joshua Bogus, Abdel N Direny, Jean Romuald Ernest, Carl R Fayette, Charles W Goss, Marisa Hast, Kobie O'Brian, Guy Emmanuel Pavilus, Daniel Frantz Sabin, Ryan E Wiegand, Gary J Weil, Jean Frantz Lemoine
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Public Library of Science (PLoS) 2020-06-01
Schriftenreihe:	PLoS Neglected Tropical Diseases
Online-Zugang:	https://doi.org/10.1371/journal.pntd.0008298
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!